ANCO Resources Related to Drug Shortages

The Association of Northern California Oncologists (ANCO) is monitoring the drug shortage crisis and is committed to providing members with the best possible information to stay informed. The medical community continues to experience shortages of critical drugs used to treat a variety of conditions. Currently, more than a dozen oncology drugs are on the FDA’s shortage list. Resources provided below:

• ANCO and MOASC Statement on Cancer Care Drug Shortage
• Articles
• Statements Addressing Ongoing Chemotherapy Shortages
• ASCO Resources Related to Drug Shortages

Articles

https://www.cnbc.com/2023/06/01/cancer-drug-shortage-fda-mulls-overseas-chemotherapy-imports.html

https://www.usatoday.com/story/news/health/2023/06/05/chemotherapy-drug-cisplatin-from-china-to-ease-shortage/70289069007/

https://www.onclive.com/view/majority-of-us-cancer-centers-report-shortages-of-cisplatin-carboplatin-chemotherapy

https://old-prod.asco.org/news-initiatives/policy-news-analysis/asco-chief-medical-officer-testifies-congress-mitigating-and

https://anco.org/site/wp-content/uploads/2023/06/TCL49-22-June-2-23.pdf

 

Statements Addressing Ongoing Chemotherapy Shortages

ANCO & MOASC – ANCO and MOASC Statement on Cancer Care Drug Shortage

ASCO – https://old-prod.asco.org/practice-patients/practice-support/drug-shortages

NCCN – https://www.nccn.org/home/news/newsdetails?NewsId=3970

SGO – https://www.sgo.org/news/drugshortage/

 

FDA Allows More Cancer Drug Imports From China as US Faces Shortages​

US regulators are allowing imports of additional supplies of a cancer drug from China amid a nationwide shortage that has forced doctors to ration care, putting patients’ lives at risk. The FDA has allowed distribution of 10 more lots of cisplatin, an essential chemotherapy drug, from Qilu Pharmaceutical Co., an agency spokesperson said Monday.
Learn More